703
Views
21
CrossRef citations to date
0
Altmetric
Target Article

Attitudes Toward Cognitive Enhancement: The Role of Metaphor and Context

, &
Pages 35-47 | Published online: 09 May 2019
 

Abstract

The widespread use of stimulants among healthy individuals to improve cognition has received growing attention; however, public attitudes toward this practice are not well understood. We determined the effect of framing metaphors and context of use on public opinion toward cognitive enhancement. We recruited 3,727 participants from the United States to complete three surveys using Amazon’s Mechanical Turk between April and July 2017. Participants read vignettes describing an individual using cognitive enhancement, varying framing metaphors (fuel versus steroid), and context of use (athletes versus students versus employees). The main outcome measure was the difference in respondent-assigned level of acceptability of the use of cognitive enhancement by others and by themselves between the contrasting vignettes. Participants were more likely to support the use of cognitive enhancement by others than by themselves and more when the use of enhancement by others was framed with a fuel metaphor than with a steroid metaphor. Metaphoric framing did not affect participants’ attitudes toward their own use. Participants supported the use of enhancement by employees more than by students or athletes. These results are discussed in relation to existing ethical and policy literature.

This article is referred to by:
“There Is No Man Living Who Isn’t Capable of Doing More Than He Thinks He Can Do” … With Cognitive Enhancement
Can Attitudes Toward Genome Editing Better Inform Cognitive Enhancement Policy?
Cognitive Enhancement and Metaphor Choice as Moral Choice
“Sounds Fine, But No Thanks!”: On Distinguishing Judgments About Action and Acceptability in Attitudes Toward Cognitive Enhancement
Consideration of Context and Meanings of Neuro-Cognitive Enhancement: The Importance of a Principled, Internationally Capable Neuroethics

DISCLOSURE STATEMENT

Erin Conrad reports no relevant disclosures. Stacey Humphries reports no relevant disclosures. Anjan Chatterjee received personal fees from Genentech for his role as a member of the Steering Committee during the conduct of the PRISMS stroke trial.

Additional information

Funding

This work was supported by The Smith Family Fund. ▪

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 137.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.